|
N=1,324 |
N=674 |
N=1,448 |
N=590 |
N=973 |
N=688 |
|
Age, median (IQR),)y |
61.7 (54.3–70.1) |
54.9 (46.8–63.9) |
59 (51–66) |
56 (49–63) |
62 (52–70) |
67 (54.5–75) |
<0.001 |
Men (%) |
79.1 |
60.7 |
76 |
80.5 |
81.0 |
73.7 |
<0.001 |
NYHA classification (%) (N=5692) |
|
|
|
|
|
|
<0.001 |
* Class I/II |
63.4 |
60.1 |
54.7 |
58.2 |
45.3 |
61.3 |
|
* Class III/IV |
36.6 |
39.9 |
31.9 |
37.4 |
46.9 |
27.5 |
|
* Not assessed |
0 |
0 |
13.5 |
4.4 |
7.8 |
11.2 |
|
Left ventricular ejection fraction, mean (SD), (%) |
24 (6.1) |
24 (6.4) |
27 (5.6) |
24 (6.3) |
26 (6.3) |
26 (6.5) |
<0.001 |
Ischemic etiology (%) (N=5469) |
61.6 |
33.1 |
42.9 |
69.4 |
45.5 |
31.8 |
<0.001 |
Systolic blood pressure, mmHg, mean (SD) (N=5663) |
113 (18) |
116 (19) |
116 (18) |
122 (22) |
120 (20) |
114 (19) |
<0.001 |
Heart rate, bpm, mean (SD) (N=5664) |
71 (11) |
72 (12) |
81 (15) |
83 (18) |
80 (17) |
77 (16) |
<0.001 |
BMI (kg/m2) (N=5494) |
30.1 (6.2) |
33.1 (8.4) |
25.0 (4.9) |
25.8 (5.8) |
24.6 (4.9) |
23.2 (4.1) |
<0.001 |
Serum creatinine, mg/dL, mean (SD) (N=4668) |
1.36 (0.9) |
1.34 (0.7) |
1.26 (0.8) |
1.59 (1.6) |
1.38 (1.1) |
1.41 (1.4) |
<0.001 |
Comorbidities, n (%) |
* Diabetes (N=5684) |
388 (29.3) |
242 (35.9) |
584 (40.3) |
278 (47.7) |
369 (38.0) |
221 (32.4) |
<0.001 |
* Atrial fibrillation/flutter (N=5685) |
327 (24.7) |
96 (14.2) |
64 (4.4) |
78 (13.4) |
238 (24.5) |
249 (35.9) |
<0.001 |
* Hypertension (N=5672) |
668 (50.8) |
510 (76.0) |
586 (40.5) |
342 (58.7) |
529 (54.4) |
328 (48.0) |
<0.001 |
* Stroke (N=5685) |
100 (7.6) |
109 (16.2) |
30 (2.1) |
39 (6.7) |
68 (7.0) |
69 (10.1) |
<0.001 |
* COPD (N=5669) |
161 (12.3) |
54 (8.1) |
73 (5.0) |
51 (8.8) |
102 (10.5) |
62 (9.1) |
<0.001 |
* Chronic kidney disease (N=4656) |
604 (51.7) |
214 (34.6) |
354 (37.3) |
258 (57.2) |
358 (43.1) |
267 (41.8) |
<0.001 |
* Smoking history (N=5677) |
891 (67.5) |
381 (56.9) |
313 (21.6) |
346 (59.3) |
530 (54.5) |
364 (53.4) |
<0.001 |
* Alcohol intake, Yes (N=5652) |
595 (45.5) |
243 (37.0) |
251 (17.3) |
73 (12.4) |
332 (34.1) |
309 (45.3) |
<0.001 |
Educational status, n (%) |
|
|
|
|
|
|
<0.001 |
* Less than high school |
158 (11.9) |
93 (13.8) |
408 (28.2) |
147 (24.9) |
358 (37.0) |
118 (18.1) |
|
* High school or equivalent |
326 (24.6) |
234 (34.7) |
444 (30.7) |
284 (48.1) |
372 (38.5) |
218 (33.4) |
|
* Some college/associate degree/diploma |
446 (33.7) |
229 (34.0) |
177 (12.2) |
68 (11.5) |
150 (15.5) |
100 (15.3) |
|
* Degree or higher |
359 (27.1) |
106 (15.7) |
371 (25.6) |
70 (11.9) |
63 (6.5) |
186 (23.5) |
|
* Decline to respond/nil |
35 (2.6) |
12 (1.8) |
48 (3.3) |
21 (3.6) |
24 (2.5) |
30 (4.6) |
|
Medications, n (%)() (N=5543) |
* Beta-blockers |
1244 (94.0) |
645 (95.7) |
937 (68.3) |
415 (74.6) |
789 (83.8) |
579 (85.8) |
<0.001 |
* ACE inhibitors/Angiotensin receptor blockers |
1236 (93.4) |
639 (94.8) |
1050 (76.5) |
428 (77.0) |
640 (67.9) |
564 (85.6) |
<0.001 |
* Mineralocorticoid receptor antagonists |
575 (43.4) |
340 (50.5) |
833 (60.7) |
310 (55.8) |
627 (66.6) |
390 (57.8) |
<0.001 |
* Diuretics |
998 (75.4) |
565 (83.8) |
1106 (80.6) |
483 (86.9) |
769 (81.6) |
541 (80.2) |
<0.001 |
All-Cause Mortality, n (%) |
57 (4.3) |
42 (6.2) |
107 (8.3) |
70 (17.4) |
116 (13.7) |
27 (4.8) |
<0.001 |